INVESTIGATIONAL DRUG CHARGES WILL BE LIMITED TO RECOVERY OF COSTS, FDA RULES IN FINAL TREATMENT IND & SALE REG; AGENCY ASSERTS AUTHORITY TO EXAMINE FINANCIAL RECORDS